These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7158263)

  • 1. [Experimental study on localization of antithrombin III at the vascular wall].
    Okajima Y; Kanayama S; Kitani T; Nakagawa M; Ijichi H
    Nihon Ketsueki Gakkai Zasshi; 1982 Nov; 45(6):1094-8. PubMed ID: 7158263
    [No Abstract]   [Full Text] [Related]  

  • 2. [Disorders of thrombin interaction with the blood vessel wall and its inactivation by antithrombin III in experimental nephrotic syndrome].
    Bashkov GV
    Biull Eksp Biol Med; 1990 Aug; 110(8):133-6. PubMed ID: 2291954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired vessel wall response to venous occlusion in patients with chronic renal failure on maintenance hemodialysis.
    Winter M; Needham J; Mackie I; Cameron JS
    Clin Nephrol; 1984 Dec; 22(6):307-13. PubMed ID: 6441660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III, the major modulator of intravascular coagulation, is synthesized by human endothelial cells.
    Chan TK; Chan V
    Thromb Haemost; 1981 Aug; 46(2):504-6. PubMed ID: 7302889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the contents and the activities of antithrombin III in plasma of rats after frostbite].
    Li F; Liu Y; Yan P; Zhang S
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 1997 Feb; 13(1):9-11. PubMed ID: 10074298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
    Hauptmann J; Brüggener E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):83-7. PubMed ID: 2459037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III metabolism in the pulmonary vessel endothelium.
    Proietta M; Pulignano I; Del Porto F; Tritapepe L; Di Giovanni C; Caronti B; Guglielmi R; Aliberti G
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):237-40. PubMed ID: 17413759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for pericellular proteoglycan in the binding of thrombin or antithrombin III by the blood vessel endothelium? The effects of proteoglycan-degrading enzymes and glycosaminoglycan-binding proteins on 125I-thrombin binding by the rabbit thoracic aorta in vitro.
    Hatton MW; Moar SL
    Thromb Haemost; 1985 Apr; 53(2):228-34. PubMed ID: 4024034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of endothelium cultured on microcarriers as a model for the microcirculation.
    Busch C; Cancilla PA; DeBault LE; Goldsmith JC; Owen WG
    Lab Invest; 1982 Nov; 47(5):498-504. PubMed ID: 6752573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of antithrombin III-protease complexes by various cells in culture.
    Savion N
    Semin Thromb Hemost; 1986 Jul; 12(3):221-2. PubMed ID: 3535078
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thrombosis and splenectomy. Preliminary note on the changes of various blood coagulation parameters 20 days after splenectomy. Experimental research].
    Di Vita G; Longo A; Di Gesù G; Avellone G; Mandalà V
    Minerva Chir; 1985 Apr; 40(8):533-6. PubMed ID: 4022410
    [No Abstract]   [Full Text] [Related]  

  • 12. [Functional characteristics of the vascular wall in experimental diabetes mellitus].
    Dolgov VV
    Patol Fiziol Eksp Ter; 1984; (3):46-9. PubMed ID: 6472895
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isolation of tissue factors of blood coagulation from vascular walls in persons with various individual-typologic personality traits].
    Mishchenko VP; Morgun ZK
    Gematol Transfuziol; 1989 Oct; 34(10):33-5. PubMed ID: 2533123
    [No Abstract]   [Full Text] [Related]  

  • 14. [Arteriovenous difference in antithrombin III activity and the antiaggregation properties of the vessel wall].
    Baluda VP; Lukoianova TI
    Biull Eksp Biol Med; 1985 Mar; 99(3):263-4. PubMed ID: 3986327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalization of antithrombin III by cultured human endothelial cells and its subcellular localization.
    van Iwaarden F; Acton DS; Sixma JJ; Meijers JC; de Groot PG; Bouma BN
    J Lab Clin Med; 1989 Jun; 113(6):717-26. PubMed ID: 2659712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antithrombin III activity in relation to multiple administration of various doses of heparin to normal animals].
    Kudriashov BA; Pastorova VE; Liapina LA
    Vopr Med Khim; 1985; 31(3):37-41. PubMed ID: 4024529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic modalities to ameliorate endotoxin induced DIC in the rats.
    Bahrami S; Paul E; Redl H; Schlag G
    Prog Clin Biol Res; 1989; 308():977-82. PubMed ID: 2780743
    [No Abstract]   [Full Text] [Related]  

  • 18. The blood vessel wall as an insulin target tissue.
    Vinters HV; Berliner JA
    Diabete Metab; 1987 Jul; 13(3 Pt 2):294-300. PubMed ID: 3308557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin, fibrinogen, prothrombin and antithrombin III variations in blood, urines and liver in rat nephrotic syndrome (Heymann nephritis).
    Girot R; Jaubert F; Leon M; Bellon B; Aiach M; Josso F; Lepelletier O; Beguin S; Monnet JP
    Thromb Haemost; 1983 Feb; 49(1):13-7. PubMed ID: 6601862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombogenicity of the injured vessel wall--role of antithrombin and heparin.
    Frebelius S; Hedin U; Swedenborg J
    Thromb Haemost; 1994 Jan; 71(1):147-53. PubMed ID: 8165634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.